Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.

The role of APOBEC3 (A3) protein family members in inhibiting retrovirus infection and mobile element retrotransposition is well established. However, the evolutionary effects these restriction factors may have had on active retroviruses such as HIV-1 are less well understood. An HIV-1 variant that...

Full description

Bibliographic Details
Main Authors: Patric Jern, Rebecca A Russell, Vinay K Pathak, John M Coffin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-04-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC2659435?pdf=render
_version_ 1818956273522049024
author Patric Jern
Rebecca A Russell
Vinay K Pathak
John M Coffin
author_facet Patric Jern
Rebecca A Russell
Vinay K Pathak
John M Coffin
author_sort Patric Jern
collection DOAJ
description The role of APOBEC3 (A3) protein family members in inhibiting retrovirus infection and mobile element retrotransposition is well established. However, the evolutionary effects these restriction factors may have had on active retroviruses such as HIV-1 are less well understood. An HIV-1 variant that has been highly G-to-A mutated is unlikely to be transmitted due to accumulation of deleterious mutations. However, G-to-A mutated hA3G target sequences within which the mutations are the least deleterious are more likely to survive selection pressure. Thus, among hA3G targets in HIV-1, the ratio of nonsynonymous to synonymous changes will increase with virus generations, leaving a footprint of past activity. To study such footprints in HIV-1 evolution, we developed an in silico model based on calculated hA3G target probabilities derived from G-to-A mutation sequence contexts in the literature. We simulated G-to-A changes iteratively in independent sequential HIV-1 infections until a stop codon was introduced into any gene. In addition to our simulation results, we observed higher ratios of nonsynonymous to synonymous mutation at hA3G targets in extant HIV-1 genomes than in their putative ancestral genomes, compared to random controls, implying that moderate levels of A3G-mediated G-to-A mutation have been a factor in HIV-1 evolution. Results from in vitro passaging experiments of HIV-1 modified to be highly susceptible to hA3G mutagenesis verified our simulation accuracy. We also used our simulation to examine the possible role of A3G-induced mutations in the origin of drug resistance. We found that hA3G activity could have been responsible for only a small increase in mutations at known drug resistance sites and propose that concerns for increased resistance to other antiviral drugs should not prevent Vif from being considered a suitable target for development of new drugs.
first_indexed 2024-12-20T10:51:20Z
format Article
id doaj.art-0f95b92f7334490a9253ea4a0be8dfe6
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-20T10:51:20Z
publishDate 2009-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-0f95b92f7334490a9253ea4a0be8dfe62022-12-21T19:43:14ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742009-04-0154e100036710.1371/journal.ppat.1000367Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.Patric JernRebecca A RussellVinay K PathakJohn M CoffinThe role of APOBEC3 (A3) protein family members in inhibiting retrovirus infection and mobile element retrotransposition is well established. However, the evolutionary effects these restriction factors may have had on active retroviruses such as HIV-1 are less well understood. An HIV-1 variant that has been highly G-to-A mutated is unlikely to be transmitted due to accumulation of deleterious mutations. However, G-to-A mutated hA3G target sequences within which the mutations are the least deleterious are more likely to survive selection pressure. Thus, among hA3G targets in HIV-1, the ratio of nonsynonymous to synonymous changes will increase with virus generations, leaving a footprint of past activity. To study such footprints in HIV-1 evolution, we developed an in silico model based on calculated hA3G target probabilities derived from G-to-A mutation sequence contexts in the literature. We simulated G-to-A changes iteratively in independent sequential HIV-1 infections until a stop codon was introduced into any gene. In addition to our simulation results, we observed higher ratios of nonsynonymous to synonymous mutation at hA3G targets in extant HIV-1 genomes than in their putative ancestral genomes, compared to random controls, implying that moderate levels of A3G-mediated G-to-A mutation have been a factor in HIV-1 evolution. Results from in vitro passaging experiments of HIV-1 modified to be highly susceptible to hA3G mutagenesis verified our simulation accuracy. We also used our simulation to examine the possible role of A3G-induced mutations in the origin of drug resistance. We found that hA3G activity could have been responsible for only a small increase in mutations at known drug resistance sites and propose that concerns for increased resistance to other antiviral drugs should not prevent Vif from being considered a suitable target for development of new drugs.http://europepmc.org/articles/PMC2659435?pdf=render
spellingShingle Patric Jern
Rebecca A Russell
Vinay K Pathak
John M Coffin
Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
PLoS Pathogens
title Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
title_full Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
title_fullStr Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
title_full_unstemmed Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
title_short Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance.
title_sort likely role of apobec3g mediated g to a mutations in hiv 1 evolution and drug resistance
url http://europepmc.org/articles/PMC2659435?pdf=render
work_keys_str_mv AT patricjern likelyroleofapobec3gmediatedgtoamutationsinhiv1evolutionanddrugresistance
AT rebeccaarussell likelyroleofapobec3gmediatedgtoamutationsinhiv1evolutionanddrugresistance
AT vinaykpathak likelyroleofapobec3gmediatedgtoamutationsinhiv1evolutionanddrugresistance
AT johnmcoffin likelyroleofapobec3gmediatedgtoamutationsinhiv1evolutionanddrugresistance